🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the makers of Tylenol, alleging the firms concealed alleged dangers that the pain reliever presented to pediatric cognitive development.

The court filing follows four weeks after President Donald Trump publicized an unverified association between consuming Tylenol - alternatively called paracetamol - throughout gestation and autism in offspring.

The attorney general is filing suit against J&J, which formerly manufactured the medication, the exclusive pain medication suggested for women during pregnancy, and the current manufacturer, which presently makes it.

In a statement, he stated they "betrayed America by gaining financially from pain and marketing drugs regardless of the potential hazards."

Kenvue says there is lacking scientific proof connecting acetaminophen to autism spectrum disorder.

"These manufacturers misled for generations, intentionally threatening millions to boost earnings," Paxton, a Republican, said.

The manufacturer commented that it was "deeply concerned by the dissemination of inaccurate information on the safety of paracetamol and the possible consequences that could have on the health of US mothers and children."

On its online platform, Kenvue also stated it had "continuously evaluated the relevant science and there is insufficient valid information that shows a verified association between using paracetamol and autism spectrum disorder."

Organizations representing physicians and healthcare providers share this view.

The American College of Obstetricians and Gynecologists has said acetaminophen - the key substance in Tylenol - is a restricted selection for expectant mothers to manage pain and fever, which can present significant medical dangers if not addressed.

"In multiple decades of investigation on the consumption of acetaminophen in pregnancy, zero credible investigations has successfully concluded that the usage of acetaminophen in any period of gestation causes neurodevelopmental disorders in young ones," the organization commented.

The court filing cites latest statements from the Trump administration in asserting the drug is reportedly hazardous.

In recent weeks, the former president raised alarms from public health officials when he advised expectant mothers to "struggle intensely" not to take acetaminophen when ill.

The US Food and Drug Administration then released a statement that medical professionals should think about restricting the use of Tylenol, while also mentioning that "a direct connection" between the medication and autism in children has not been proven.

Health Secretary Robert F Kennedy Jr, who oversees the FDA, had vowed in April to initiate "extensive scientific investigation" that would identify the origin of autism spectrum disorder in a matter of months.

But specialists advised that discovering a single cause of autism spectrum disorder - believed by scientists to be the consequence of a complex mix of inherited and surrounding conditions - would not be simple.

Autism spectrum disorder is a category of permanent neurological difference and impairment that affects how people perceive and relate to the environment, and is identified using medical professional evaluations.

In his court filing, Paxton - who supports Trump who is running for US Senate - asserts Kenvue and Johnson & Johnson "deliberately disregarded and sought to suppress the evidence" around paracetamol and autism.

This legal action attempts to require the corporations "eliminate any promotional materials" that states Tylenol is secure for expectant mothers.

The Texas lawsuit echoes the concerns of a assembly of parents of young ones with autism spectrum disorder and ADHD who sued the manufacturers of Tylenol in two years ago.

A federal judge threw out the lawsuit, saying studies from the family's specialists was lacking definitive proof.